Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Charts
  • Login - Join Now!
  1. Home ›
  2. Stock Message Boards ›
  3. Stock Boards ›
  4. Citius Pharmaceuticals Inc. (CTXR)


Hide Board Information
Show Board Information

Citius Pharmaceuticals Inc. CTXR

CTXR RSS Feed
Board Mod: Add me as mod
Asst Mods:
Last Post: 04/06/2017 9:23:12 AM
Board Marks: 0
Posts Today: 0
Board Views Today: 2
<span style="font-size: medium;"><strong>Trail One, Inc. (TRLO) </strong></span><br /><br /><span style="font-size: medium;"><strong>Company Website: <a rel="nofollow" href="http://www.trialonecnc.com/" target="_blank">http://www.trialonecnc.com/</a></strong></span><br />

Citius Pharmaceuticals Inc. (CTXR) Recent Headlines

Citius Pharmaceuticals to Present at NobleCon15 Investor Conference

CRANFORD, N.J. , Jan. 25, 2019 /PRNewswire/ -- Citius Pharmaceuticals, Inc. ("Citius") (CTXR), a specialty pharmaceutical company focused on adjunctive cancer care and critical care drug products, ...

Citius Licenses Mino-Wrap From MD Anderson Cancer Center

CRANFORD, N.J., Jan. 8, 2019 /PRNewswire/ -- Citius Pharmaceuticals, Inc. ("Citius") ("Company") (CTXR), a specialty pharmaceutical company focused on adjunctive cancer care and critical care drug products, today reported that a definitive license agreement has been reached with MD Anderson Cancer Center ("MDACC") to develop and commercialize a novel approach to reducing post-operative infections associated with surgical implants. There are approximately 100,000 patients in the U.S. undergoing breast reconstruction procedures following mastectomies.

Citius Pharmaceuticals to Present at Biotech Showcase Investor Conference

CRANFORD, N.J. , Jan. 4, 2019 /PRNewswire/ -- Citius Pharmaceuticals, Inc. ("Citius") (CTXR), a specialty pharmaceutical company focused on adjunctive cancer care and critical care drug products, ...

Citius Pharmaceuticals Provides Updates on Mino-Lok® and CITI-002

CRANFORD, N.J., Dec. 19, 2018 /PRNewswire/ -- Citius Pharmaceuticals, Inc. ("Citius") (CTXR), a specialty pharmaceutical company focused on adjunctive cancer care and critical care drug products, provided a status report today on Mino-Lok® and CITI-002. Mr. Myron Holubiak, CEO of Citius, said, "While there are significant challenges involved with studying an adjunctive therapy in patients with underlying serious life-threatening diseases, we are extremely pleased with the progress that has been made in the Phase-3 Mino-Lok® clinical trials.

Citius Pharmaceuticals Presentation Now Available for On-Demand Viewing

Company invites individual and institutional investors as well as advisors to log-on to VirtualInvestorConferences.com to view presentation CRANFORD, N.J. , Dec. 10, 2018 /PRNewswire/ -- Citius Pharmaceuticals ...

Live Investor Conference & Webinar: NYSE, NASDAQ, and OTC companies present December 6th

Company executives share vision, answer questions live at VirtualInvestorConferences.com NEW YORK , Dec. 4, 2018 /PRNewswire/ -- PR Newswire and BetterInvesting (NAIC) today announced the agenda for the ...

Citius Pharmaceuticals to Present at the 11th Annual LD Micro Main Event

CRANFORD, N.J. , Nov. 30, 2018 /PRNewswire/ -- Citius Pharmaceuticals, Inc. ("Citius") (NASDAQ: CTXR), a specialty pharmaceutical company focused on adjunctive cancer care and critical care drug ...

Citius Pharmaceuticals to Webcast, Live, at VirtualInvestorConferences.com December 6

Company invites individual and institutional investors as well as advisors to attend interactive real-time virtual VirtualInvestorConferences.com CRANFORD, N.J. , Nov. 29, 2018 /PRNewswire/ --  Citius ...

Citius Pharmaceuticals to Present at Dawson James Securities 4th Annual Small Cap Growth Conference

CRANFORD, N.J. , Oct. 25, 2018 /PRNewswire/ -- Citius Pharmaceuticals, Inc. (NASDAQ: CTXR), a specialty pharmaceutical company dedicated to developing and commercializing adjunctive cancer care and critical ...

Citius Reports On Activities During Infectious Disease Week 2018

The Citius Scientific Advisory Board (SAB) meeting was held on October 4 to discuss the progress of the Mino-Lok® pivotal phase 3 trial and the design of the second trial (if needed). A meeting of many of the principal investigators of the Mino-Lok® pivotal phase 3 trial was also held on October 4, 2018.

Citius Pharmaceuticals Inc. (CTXR) Research Links

Company Profiles

OTC Markets , OTCBB , Reuters ,

Yahoo! Finance

Management

Business Week , Reuters , Yahoo! Finance

Research Reports

Reuters , Fidelity , The Street , Yahoo! Finance

Recent News

OTC Markets , Market Wire , Business Wire ,

PR News Wire , Reuters , Bloomberg ,

Aggregated News at Google ,

Aggregated News at Yahoo!

Financials

OTC Markets , Google , Business Week ,

Money Central , Reuters , CNBC

Earnings

MSN Money , Business Week , Fidelity ,

The Street , Earnings Whisper

SEC Filings

SEC , Free Edgar , OTC Markets , OTCBB

Transcripts

Morning Star

Short Sale Data

OTC Markets , NASDAQ ,

Short Squeeze , Daily Finance

Trading Info

Ameritrade , Trading Software from E Signal ,

Trading Software from Trade Station

Is CTXR a Buy?

Barchart

Commentary

Market Watch , CNBC , The Street ,

Zacks , Motley Fool , 24/7 Wall St.

Blogs

Blogging Stocks , Google's Blog Search ,

Market Minute , Motley Fool

Share Statistics

Barchart , Fidelity , Yahoo! Finance ,

Smart Money

Share Holders

Morningstar

Quotes

OTC Markets , Barchart

Technical Analysis

Barchart

Stock Charts

OTC Markets , Google , Stock Charts ,

Big Charts , Stock TA , Barchart ,

MSN Money , Y Charts , Investor Guide ,

FinViz , Clear Station

Free Level 2

AIStockCharts , Level2StockQuotes

Search Investors Hangout

Search Investors Hangout

Citius Pharmaceuticals Inc. (OTCMRKTS: CTXR) Stock Message Board



  1.  
  2.  
  3.  
  4.  
  5.  




Create New Post View All Posts Board Mark Banned
Post
Subject
Author
Posted On
5 CTXR ready to run today.. Full AllReward 04/06/2017 9:23:12 AM
4 #CitiusPharmaceuticals, Inc. $CTXR a specialty ipoguy1 09/22/2016 12:35:25 PM
3 The market has been on fire of late as investment saanalyst 07/17/2016 12:12:02 PM
2 TRLO n/a Stock Charts $TRLO 1 Month Chart chartguy89 03/10/2014 8:24:26 AM
1 TRLO Stock Charts Last: UNCH Sunday, March 2, chartguy89 03/02/2014 2:22:02 AM

Investors Hangout

Home

Mailbox

Boards

Favorites

Whats Hot

Settings

Ad Page

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

OTC BB & Pinks (US OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Google+

Facebook

50 Blog Posts

© 2018 Copyright Investors Hangout, LLC All Rights Reserved.

Mobile |Privacy Policy | Terms & Conditions | Disclaimer | Help | Contact Us

Financial Market Data powered by Quotemedia.com. All rights reserved. View the Terms of Use.NYSE/AMEX data delayed 20 minutes. NASDAQ and other data delayed 15 minutes unless indicated.


Why pay others when you can get more data here FREE when you join?
Company Profiles, News, Filings, Financials, Buy Ratings, Time & Sales, Message Boards & More!
Stock Message Board Stock Quotes
Stock Message Board Time and Sales
Join Now! - 100% FREE
I agree by the Terms and conditions
Member Login
Lost password?